The Cure Alliance Press Releases

• Published on October 29, 2024 - 10:00 GMT

  

  First Three Patients with T1D Successfully Transplanted with Novel Antibody to Eliminate Harsh Anti-rejection Drug

  Stunning Results of First Human Trials Presented Today in Boston at 5th Summit on Stem Cell Derived Islets MIAMI, FL, UNITED STATES, October 29, 2024 /⁨EINPresswire.com⁩/ -- The Cure Alliance, a 501(c)(3) nonprofit, is excited to announce that three …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on May 8, 2024 - 10:00 GMT

  

  U of Chicago Docs Perform First Human Islet Transplant Successfully Using Antibody To Replace Toxic Anti-Rejection Drug

  A critical step to cure millions with diabetes: Chicago woman is first to have successful human islet transplant using novel antibody to prevent rejection. MIAMI, FLORIDA, USA, May 8, 2024 /⁨EINPresswire.com⁩/ -- The Cure Alliance, a 501(c)(3) nonprofit, …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on October 16, 2023 - 21:35 GMT

  The Cure Alliance Sends Key Funding For 1st Human Islet Transplant Using Novel Drug to Replace Toxic Anti-Rejection Drug

  U of Chicago to use novel antibody to replace tacrolimus, the harsh anti-rejection drug associated with increased risk of severe side effects. MIAMI, FLORIDA, UNITED STATES, October 16, 2023 /⁨EINPresswire.com⁩/ -- The Cure Alliance, a 501(c)(3) …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on July 5, 2023 - 00:00 GMT

  The Cure Alliance Gets IRB Approval for "C3" Clinical Trial To Treat Deadliest Pancreatic Cancer AT SUNY Downstate

  "C3," a Combination of 3 Generic Drugs Designed to Halt Advanced Adenocarcinoma Pancreatic Cancer Moves from the Lab to Human Trials MIAMI, FLORIDA, UNITED STATES, July 4, 2023 /⁨EINPresswire.com⁩/ -- The Cure Alliance, 501(c)(3) non-profit, …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...